BiotechTube
Home/Xynomic Pharmaceuticals/Y. Mark Xu
YM

Y. Mark Xu

CEO/Spokesperson (inferred from news item)

Xynomic Pharmaceuticals

Roles

CEO/Spokesperson (inferred from news item)atXynomic Pharmaceuticals
CEOatLaekna Therapeutics

Therapeutic Areas

Oncology

Xynomic Pharmaceuticals Pipeline

DrugIndicationPhase
AbexinostatRenal Cell Carcinoma (Kidney Cancer)Phase 3
Abexinostat + PembrolizumabMultiple Solid TumorsPhase 1b